Nationwide Fund Advisors’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-9,138
| Closed | -$105K | – | 3054 |
|
|
2017
Q3 | $105K | Sell |
9,138
-1
| -0% | -$11 | ﹤0.01% | 2879 |
|
|
2017
Q2 | $89K | Sell |
9,139
-3,737
| -29% | -$36.4K | ﹤0.01% | 2949 |
|
|
2017
Q1 | $312K | Sell |
12,876
-1,408
| -10% | -$34.1K | ﹤0.01% | 2397 |
|
|
2016
Q4 | $459K | Sell |
14,284
-525
| -4% | -$16.9K | ﹤0.01% | 2213 |
|
|
2016
Q3 | $740K | Sell |
14,809
-508
| -3% | -$25.4K | ﹤0.01% | 1963 |
|
|
2016
Q2 | $650K | Buy |
15,317
+3,444
| +29% | +$146K | ﹤0.01% | 2000 |
|
|
2016
Q1 | $782K | Buy |
11,873
+58
| +0.5% | +$3.82K | ﹤0.01% | 1845 |
|
|
2015
Q4 | $734K | Buy |
11,815
+2,761
| +30% | +$172K | ﹤0.01% | 1893 |
|
|
2015
Q3 | $606K | Hold |
9,054
| – | – | ﹤0.01% | 1991 |
|
|
2015
Q2 | $881K | Sell |
9,054
-79
| -0.9% | -$7.69K | ﹤0.01% | 1933 |
|
|
2015
Q1 | $854K | Sell |
9,133
-366
| -4% | -$34.2K | ﹤0.01% | 1964 |
|
|
2014
Q4 | $845K | Sell |
9,499
-88
| -0.9% | -$7.83K | ﹤0.01% | 1898 |
|
|
2014
Q3 | $662K | Sell |
9,587
-43
| -0.4% | -$2.97K | ﹤0.01% | 2049 |
|
|
2014
Q2 | $552K | Buy |
9,630
+134
| +1% | +$7.68K | ﹤0.01% | 2209 |
|
|
2014
Q1 | $377K | Hold |
9,496
| – | – | ﹤0.01% | 2195 |
|
|
2013
Q4 | $399K | Sell |
9,496
-244
| -3% | -$10.3K | ﹤0.01% | 2345 |
|
|
2013
Q3 | $291K | Buy |
9,740
+5,179
| +114% | +$155K | ﹤0.01% | 2485 |
|
|
2013
Q2 | $242K | Buy |
+4,561
| New | +$242K | ﹤0.01% | 2397 |
|